3',4'-dihydrospiro[adamantane-2,2'-pyrrole]-5'-ol

ID: ALA1172240

PubChem CID: 10442952

Max Phase: Preclinical

Molecular Formula: C13H19NO

Molecular Weight: 205.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CCC2(N1)C1CC3CC(C1)CC2C3

Standard InChI:  InChI=1S/C13H19NO/c15-12-1-2-13(14-12)10-4-8-3-9(6-10)7-11(13)5-8/h8-11H,1-7H2,(H,14,15)

Standard InChI Key:  CGXGSOKIYGVUOZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 18  0  0  0  0  0  0  0  0999 V2000
    6.3191   -8.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0912   -8.1109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6114   -8.7530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1588   -9.4474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3628   -9.2293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2575  -10.6577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8997   -9.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0589  -10.4323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6080  -10.2361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8128  -10.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3569  -10.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0563   -9.5786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6137   -8.9197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8911   -9.1764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4365   -8.7103    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  4  5  1  0
  5  1  1  0
  1  2  1  0
  2  3  1  0
  6  7  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 11  1  0
 12 13  1  0
  8 12  1  0
  7 14  1  0
 11  5  1  0
  5 13  1  0
 13 14  1  0
  3  4  1  0
  3 15  2  0
M  END

Alternative Forms

Associated Targets(non-human)

M Matrix protein 2 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 205.30Molecular Weight (Monoisotopic): 205.1467AlogP: 2.09#Rotatable Bonds:
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.52CX LogD: 1.52
Aromatic Rings: Heavy Atoms: 15QED Weighted: 0.64Np Likeness Score: 0.68

References

1. Eleftheratos S, Spearpoint P, Ortore G, Kolocouris A, Martinelli A, Martin S, Hay A..  (2010)  Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.,  20  (14): [PMID:20570509] [10.1016/j.bmcl.2010.05.049]

Source